Ensuring quality control in a clinical trial during the COVID-19 pandemic: The experience of the Inserm C20-15 DisCoVeRy study in France

Ensuring quality control in a clinical trial during the COVID-19 pandemic: The experience of the Inserm C20-15 DisCoVeRy study in France

Meeting Abstract PM2-027

Saved in:
Bibliographic Details
Published in:Fundamental & clinical pharmacology Vol. 36; p. 85
Main Authors: Fougerou-Leurent, C., Delmas, C., Saillard, J., Dumousseaux, M., Ferrane, A., Mercier, N., Terzic, V., Le Mestre, S., Dechanet, A., Noret, M., Diallo, A., Couffin-Cadiergues, S., Esperou, H.
Format: Journal Article
Language:English
Published: Wiley 2022
Subjects:
Life Sciences
sponsor
quality control
monitoring
consent
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Meeting Abstract PM2-027
ISSN:0767-3981
1472-8206